MRC1 and Leigh syndrome: In recent decades, knowledge of the genotype-phenotype correlations for each LS gene has allowed the development of risk reduction management protocols for patients with pathogenic variants in MMR genes.(6) Complete anamnesis (including family history), tumor pathology, microsatellite instability analysis, and immunohistochemistry of MMR proteins are crucial for guiding the diagnosis and management of LS.